Assessing pulmonary disease and response to therapy: Which test?

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 4, 2010, Pages 409-418

  Keir, Greg ^a   Wells, Athol U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

identification of change; Pulmonary sarcoidosis; staging of disease severity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM 67; INTERLEUKIN 2 RECEPTOR; BIOLOGICAL MARKER;

BRONCHOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; HIGH RESOLUTION COMPUTED TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SCINTISCANNING; THORAX RADIOGRAPHY; TREATMENT RESPONSE; DISEASE COURSE; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 77955026314     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1262209     Document Type: Review

References (45)

1. Turner-Warwick M, McAllister W, Lawrence R, Britten A, Haslam P L. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Thorax 1986 41 903-913
2. Keogh B A., Crystal R G. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest 1980 78 856-865
3. Neville E, Walker A, James D G. Prognostic factors predicting outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983 52 525-533
4. Rmer F K. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 1982 29 27-32
5. Alhamad E H., Lynch J P. III, Martinez F J. Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med 2001 22 715-750 ix
6. Harrison B D., Shaylor J M., Stokes T C., Wilkes A R. Airflow limitation in sarcoidosisa study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991 85 59-64
7. Lynch J P. III, Kazerooni E A., Gay S E. Pulmonary sarcoidosis. Clin Chest Med 1997 18 755-785
8. Gleeson F V., Traill Z C., Hansell D M. Evidence of expiratory CT scans of small-airway obstruction in sarcoidosis. AJR Am J Roentgenol 1996 166 1052-1054
9. Hansell D M., Milne D G., Wilsher M L., Wells A U. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin section CT. Radiology 1998 209 697-704
10. Chambellan A, Turbie P, Nunes H, Brauner M, Battesti J P., Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest 2005 127 472-481
11. Carrington C B. Structure and function in sarcoidosis. Ann N Y Acad Sci 1976 278 265-283
12. Levinson R S., Metzger L F., Stanley N N. et al. Airway function in sarcoidosis. Am J Med 1977 62 51-59
13. Shorr A F., Davies D B., Nathan S D. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003 124 922-928
14. Baughman R P., Engel P J., Meyer C A., Barrett A B., Lower E E. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 23 108-116
15. Scadding J G. Prognosis of intrathoracic sarcoidosis in England. BMJ 1961 2 1165-1172
16. Israel H L., Lenchner G, Steiner R M. Late development of mediastinal calcification in sarcoidosis. Am Rev Respir Dis 1981 124 302-305
17. Gawne-Cain M L., Hansell D M. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol 1996 51 263-267
18. Smellie H, Hoyle C. The natural history of pulmonary sarcoidosis. Q J Med 1960 29 539-558
19. Ellis K, Renthal G. Pulmonary sarcoidosis. Roentgenographic observations on course of disease. AJR Am J Roentgenol 1962 88 1070-1083
20. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001 7 255-261
21. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994 191 675-680
22. Hansell D M., Armstrong P, Lynch D A., McAdams H P. Imaging of Diseases of the Chest. 4th ed. Philadelphia Elsevier Mosby 2005 635-636
23. Drent M, De Vries J, Lenters M et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003 13 2462-2471
24. Oberstein A, von Zitzewitz H, Schweden F, Mller-Quernheim J. Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis 1997 14 65-72 (Pubitemid 27170557)
25. Khn H, Klech H, Mostbeck A, Kummer F. 67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med 1982 7 413-416
26. Nishiyama Y, Yamamoto Y, Fukunaga K et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006 47 1571-1576
27. Braun J J., Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008 35 1537-1543
28. Teirstein A S., Machac J, Almeida O, Lu P, Padilla M L., Iannuzzi M C. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007 132 1949-1953
29. Keijsers R GM, Verzijlbergen J F., van Diepen D M., van den Bosch J MM, Grutters J C. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2008 25 143-149
30. Ziegenhagen M W., Rothe M E., Schlaak M, Mller-Quernheim J. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003 21 407-413
31. Drent M, Jacobs J A., de Vries J, Lamers R JS, Liem I H., Wouters E FM. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999 13 1338-1344
32. Shorr A F., Torrington K G., Parker J M. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med 1997 91 399-401
33. Leung A N., Brauner M W., Caillat-Vigneron N, Valeyre D, Grenier P. Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr 1998 22 229-234
34. Stokes G S., Monaghan J C., Schrader A P., Glenn C L., Ryan M, Morris B J. Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity. Aust N Z J Med 1999 29 315-318
35. Bradley B, Branley H M., Egan J J. et al, British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee Thoracic Society of Australia New Zealand Thoracic Society Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008 63 (Suppl 5) v1-v58
36. Ziegenhagen M W., Benner U K., Zissel G, Zabel P, Schlaak M, Mller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997 156 1586-1592
37. Keicho N, Kitamura K, Takaku F, Yotsumoto H. Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. Chest 1990 98 1125-1129
38. Grutters J C., Fellrath J M., Mulder L, Janssen R, van den Bosch J M., van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003 124 186-195
39. Mller-Quernheim J, Pfeifer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Dis 1991 144 1322-1329
40. ILO Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconioses. Geneva International Labor Office 1980 Occupational Safety Series No. 22
41. Judson M A., Gilbert G E., Rodgers J K., Greer C F., Schabel S I. The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology 2008 13 97-102
42. Gibson G J., Prescott R J., Muers M F. et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996 51 238-247
43. Muers M F., Middleton W G., Gibson G J. et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis 1997 14 46-56
44. Baughman R P., Shipley R, Desai S et al, Sarcoidosis Investigators. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009 136 526-535
45. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on Sarcoidosis. Am J Respir Crit Care Med 1999 160 736-755